LUT014 for the Treatment of Radiation Induced Dermatitis in Breast Cancer Patients
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Radiation Dermatitis
Interventions: DRUG: LUT014 Gel|DRUG: Placebo for LUT014 Gel
Sponsor: Lutris Pharma Ltd.